Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding JPH et al., NEJM 2021 68-week phase-3 Wegovy registration trial
Glutathione is known for its skin-lightening properties
Rong Xu , senior author of the study, while semaglutide may not directly treat Alzheimers, it addresses key risk factors that contribute to cognitive decline and neuroinflammation , positioning it as a potential breakthrough therapy in Alzheimers prevention
The article states that berberine is not recommended as monotherapy for type 2 diabetes or for obesity requiring significant metabolic intervention, and that its effects plateau at modest levels
John Myers was one of the first physicians to promote the use of intravenous nutrient therapy
Keep reading Published on: March 11, 2026 Walk Through a 7-Foot Colon Model and Learn About Screenings at Wellstar Events Early detection is the best prevention, especially when it comes to colon cancer